|
A united states customer submitted their cap d-08 2018 alcaligenes faecalis ssp faecalis strain for piperacillin/tazobactam (tzp) evaluation because the customer reported resistant tzp results, but the expected result was susceptible.The customer originally tested the organism on vitek® 2 ast-gn69 lot 5890692203 and obtained a tzp mic>=128.Upon repeat testing, the result was susceptible (mic<=4).Additionally, the organism was tested on microscan walkaway, where a susceptible mic<=16 was obtained.Biomérieux internal investigation was conducted.The customer's cap d-08 strain and the internal biomerieux cap d-08 survey strain were sub-cultured on tsab media and identification to alcaligenes faecalis ssp faecalis was confirmed.Testing was performed on the customer lot and a random lot of ast-gn69 cards.Broth microdilution (bmd), the reference method for tzp (tzp03n) development, was also performed.911735 (customer's d-08 strain): on the customer lot of ast-gn69 cards, an intermediate mic=64 was obtained, on the random lot, a susceptible mic<=4 was obtained.Bmd gave a susceptible mic<=4.Card and reference method are in agreement for the random lot, but the customer lot result is a minor category error when compared to reference method.911704 (internal d-08 strain): on the customer lot of ast-gn69 cards, an intermediate mic=64 was obtained, on the random lot, a susceptible mic<=4 was obtained.Bmd gave a susceptible mic<=4.Card and reference method are in agreement for the random lot, but the customer lot result is a minor category error when compared to reference method.The investigation concluded the cap d-08 2018 strain to be an atypical strain.
|